Iimpawu zoMsebenzi
Umda wokufumanisa: 2.0ng / mL;
Uluhlu lweMila: 2.0 ~ 100ng/mL
Umgca wolungelelwaniso i-coefficient R> 0.990:
Ukuchaneka: ngaphakathi kwibhetshi iCV yi< 15%;phakathi kweebhetshi i-CV yi< 20%;
Ukuchaneka: ukutenxa okunxulumeneyo kweziphumo zomlinganiselo akuyi kudlula ±15% xa isikali sokuchaneka esilungiswe ngumgangatho wesizwe we-CK-MB okanye isilinganisi sokuchaneka esisemgangathweni sivavanywa.
1. Gcina i-detector buffer ku-2~30℃.Isithinteli sizinzile ukuya kwiinyanga ezili-18.
2. Gcina i-Aehealth Ferritin Rapid Quantitative test cassette kwi-2~30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.
3. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.
I-MB Isoenzyme ye-Creatine Kinase (CK-MB) yi-84,000 ye-enzyme yobunzima be-molecular emele inxalenye ebalulekileyo ye-creatine kinase ekhoyo kwi-myocardial tissue.I-CK-ME ikhona kwiindidi zezinye izihlunu, nangona kumanqanaba asezantsi kakhulu.Ukubonakala kwe-CK-MB kwi-serum, ngokungabikho kokuphazamiseka okukhulu kwemisipha, kunokubonisa umonakalo wenhliziyo kwaye ngaloo ndlela.imyocardial infarction.Ngapha koko, ipateni yethutyana yokukhululwa kwe-CK-ME elandela i-infarction ibalulekile.Ngaloo ndlela, ixabiso le-CK-MB elibonisa ukuba akukho Utshintsho oluphawulekayo ekuhambeni kwexesha aluqinisekisi i-myocardial infarction.Uvavanyo lwe-CK-MB luye lwabikwa luluncedo ekumiseleni ukusebenza kokubuyisela kwakhona emva kwe-acute coronary thrombosis.